Drug compositions to prevent desensitization of cellular receptors
OwnerRichard G. Lanzarainventor
Life of this patent
Estimating the term…
Loading patent…
OwnerRichard G. Lanzarainventor
Estimating the term…
Drug compositions combining antagonists with agonists to prevent desensitization of cellular receptors. An agonist is a substance or drug that produces a maximal or nearly maximal response, whereas an antagonist is a substance or molecule that produces no response, but can block the action of the agonist/drug. A partial agonist produces a moderate response and can also block the response of the receptor to the agonist/drug. The instant invention solves the problem of determining the optimal concentration of an antagonist or inhibitor which is necessary to prevent desensitization, without causing unnecessary and unwanted inhibition, by providing a formulative method detailing how a competitive antagonist of the receptor should be combined with an agonist in a specific proportion to maximize and maintain receptor response throughout drug therapy/administration. Use of the “optimal ratio method” to determine a specific agonist/antagonist composition to prevent β2 receptor desensitization is experimentally verified and validated.
A formulation that elicits a desired response from cellular receptors and prevents subsequent desensitization of said receptors comprising an agonist suitable for eliciting said response in a first amount effective for binding to said receptors in both a high and a low affinity state effective for obtaining said response mixed with an inhibitor of said agonist specific to said receptors, said inhibitor in a second amount sufficient to prevent desensitization of said receptor, said second amount being Ki (KDLKDH/2)−½ of said first amount, where KDL and KDH are dissociation constants of said agonist in low and high affinity states, respectively, and Ki is the dissociation constant of said inhibitor.
A formulation which elicits a desired response from a cellular receptor while preventing subsequent desensitization of said receptor and consisting essentially of:
A formulation containing an optimal ratio of an antagonist mixed with an agonist for preventing desensitization of agonist—specific cell receptors and maximizing response by said receptors comprising:
Dependencies are inferred from the claim text.